Back to search
FDAFDA · Food and drugs·Recall number D-1065-2014

Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3428-05.

Published February 12, 2014 · Recall initiated: November 13, 2013

Summary

FDA records drug Class III recall D-1065-2014, published February 12, 2014 and initiated November 13, 2013. Recalling firm: Forest Pharmaceuticals Inc; Status: Terminated; Reported quantity: 111,384 sample packs; Lot: Lot 1112467 Exp. 02/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Forest Pharmaceuticals Inc
Distributor
Nationwide and Puerto Rico.
Lot
Lot 1112467 Exp. 02/15
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3428-05. recalled?

Yes. FDA published recall D-1065-2014 on February 12, 2014. Reported hazard: Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter